Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1276-1282

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anthonsen, M. W.
Right arrow Articles by Johansen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anthonsen, M. W.
Right arrow Articles by Johansen, B.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Lipid and lipoprotein metabolism
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:1276.)
© 2000 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Mildly Oxidized LDL Induces Expression of Group IIa Secretory Phospholipase A2 in Human Monocyte–Derived Macrophages

Marit W. Anthonsen; Dominique Stengel; Delphine Hourton; Ewa Ninio; Berit Johansen

From the UNIGEN Center for Molecular Biology (M.W.A., B.J.), Norwegian University of Science and Technology, Trondheim, Norway; and Institut National de la Sante et de la Recherche Medicale (INSERM) Unit 321 (D.S., D.H., E.N.), Lipoproteines et Atherogenese, Hopital de la Pitie, Paris, France.

Correspondence to Berit Johansen, UNIGEN Center for Molecular Biology, Norwegian University of Science and Technology, N-7489 Trondheim, Norway. E-mail Berit.Johansen{at}chembio.ntnu.no

Abstract—Phospholipase A2s (PLA2s) constitute a family of enzymes that hydrolyze fatty acids of membrane phospholipids, thus initiating the synthesis of proinflammatory mediators. Various PLA2s have been detected in human atherosclerotic arteries (advanced lesions); however, only the secretory group of PLA2 has been shown to specifically hydrolyze low density lipoprotein (LDL)–associated phospholipids and, as such, may play a potential role in atherogenesis. In the present study, we investigated the expression pattern of group IIa, IV, and V PLA2s in human macrophages, which are the key cells involved in the onset and perpetuation of atherosclerosis. Immunohistochemical staining by double labeling showed that the secretory nonpancreatic PLA2 (snpPLA2) is detectable in macrophages in the intima of early atherosclerotic lesions. Reverse transcription–polymerase chain reaction analysis of RNA extracted from human monocytes clearly showed that expression of group IV PLA2 was enhanced during differentiation into macrophages, with an onset of induction at days 2 to 3 of differentiation. Group V snpPLA2 was constitutively expressed on differentiation, whereas the detection of group IIa snpPLA2 was dependent on both differentiation and subsequent stimulation of macrophages. Indeed, the transcription of group IIa snpPLA2 in macrophages was induced by treatment with minimally modified or mildly oxidized LDL, whereas native, extensively oxidized, or acetylated LDL had no effect. To our knowledge, this is the first report describing induction of group IIa snpPLA2 expression in human monocyte–derived macrophages. The mRNA levels of cytosolic PLA2 group IV and snpPLA2 group V remained unchanged on LDL treatment. Thus, our results show that the expression of distinct PLA2 enzymes is regulated not only during differentiation of monocytes into macrophages but also on exposure of macrophages to distinct LDL species. Consequently, our results indicate a potential role for both cytosolic and secretory PLA2 enzymes in inflammation and in macrophage functions related to atherosclerosis, with a specific role for group IIa snpPLA2 in LDL scavenging.


Key Words: atherosclerosis • phospholipase A2 • LDL • immunohistochemistry • macrophages




This article has been cited by other articles:


Home page
Eur Heart JHome page
W. Koenig, C. Y. Vossen, Z. Mallat, H. Brenner, J. Benessiano, and D. Rothenbacher
Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
Eur. Heart J., November 2, 2009; 30(22): 2742 - 2748.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Koenig and N. Khuseyinova
Biomarkers of Atherosclerotic Plaque Instability and Rupture
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Rosengren, H. Peilot, M. Umaerus, A.-C. Jonsson-Rylander, L. Mattsson-Hulten, C. Hallberg, P. Cronet, M. Rodriguez-Lee, and E. Hurt-Camejo
Secretory Phospholipase A2 Group V: Lesion Distribution, Activation by Arterial Proteoglycans, and Induction in Aorta by a Western Diet
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1579 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Boekholdt, T. T. Keller, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, M. S. Sandhu, J. W. Jukema, J. J.P. Kastelein, C. E. Hack, et al.
Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 839 - 846.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. A. I. Ghesquiere, M. J. J. Gijbels, M. Anthonsen, P. J. J. van Gorp, I. van der Made, B. Johansen, M. H. Hofker, and M. P. J. de Winther
Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition
J. Lipid Res., February 1, 2005; 46(2): 201 - 210.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. Whatling, H. Bjork, S. Gredmark, A. Hamsten, and P. Eriksson
Effect of macrophage differentiation and exposure to mildly oxidized LDL on the proteolytic repertoire of THP-1 monocytes
J. Lipid Res., September 1, 2004; 45(9): 1768 - 1776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. Szmitko, C.-H. Wang, R. D. Weisel, G. A. Jeffries, T. J. Anderson, and S. Verma
Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II
Circulation, October 28, 2003; 108(17): 2041 - 2048.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. S. Barbieri, S. Eligini, M. Brambilla, E. Tremoli, and S. Colli
Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase
Cardiovasc Res, October 15, 2003; 60(1): 187 - 197.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Akiba, Y. Yoneda, S. Ohno, M. Nemoto, and T. Sato
Oxidized LDL activates phospholipase A2 to supply fatty acids required for cholesterol esterification
J. Lipid Res., September 1, 2003; 44(9): 1676 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. R. Webb, M. A. Bostrom, S. J. Szilvassy, D. R. van der Westhuyzen, A. Daugherty, and F. C. de Beer
Macrophage-Expressed Group IIA Secretory Phospholipase A2 Increases Atherosclerotic Lesion Formation in LDL Receptor-Deficient Mice
Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 263 - 268.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Fuentes, M. Hernandez, F. J. Fernandez-Aviles, M. S. Crespo, and M. L. Nieto
Cooperation Between Secretory Phospholipase A2 and TNF-Receptor Superfamily Signaling: Implications for the Inflammatory Response in Atherogenesis
Circ. Res., October 18, 2002; 91(8): 681 - 688.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. MERTENS and P. HOLVOET
Oxidized LDL and HDL: antagonists in atherothrombosis
FASEB J, October 1, 2001; 15(12): 2073 - 2084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. W. Anthonsen, A. Solhaug, and B. Johansen
Functional Coupling between Secretory and Cytosolic Phospholipase A2 Modulates Tumor Necrosis Factor-alpha - and Interleukin-1beta -induced NF-kappa B Activation
J. Biol. Chem., August 3, 2001; 276(32): 30527 - 30536.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Hernandez, L. Fuentes, F. J. Fernandez Aviles, M. S. Crespo, and M. L. Nieto
Secretory Phospholipase A2 Elicits Proinflammatory Changes and Upregulates the Surface Expression of Fas Ligand in Monocytic Cells: Potential Relevance for Atherogenesis
Circ. Res., January 11, 2002; 90(1): 38 - 45.
[Abstract] [Full Text] [PDF]